Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 97,368

Document Document Title
WO/2017/094776A1
The purpose of the present invention is to provide a cytochrome b-glucose dehydrogenase fused protein having modified electron transfer characteristics, and a glucose measurement method and a measurement kit that use the fused protein. P...  
WO/2017/096324A1
The invention provides methods for improving efficiency of fermentation by arginine supplementation, and genetically modified bacterium for use therefor. More particularly the invention provides methods for (i) increasing the production ...  
WO/2017/093291A1
Described herein are methods of producing glycosylated proteins in vitro and in vivo. The methods include using host cells to produce glycosylated proteins. Also described herein are glycosylated proteins produced using such methods and ...  
WO/2017/094785A1
Although promising as feedstock for biomass fuel, green algae is inhibited by intense light during mass culturing outdoors in the summer, leading to a reduction in biomass productivity. The purpose of the present invention is to isolate ...  
WO/2017/092513A1
Provided are an angular dioxygenase gene dpeA1A2 and the use thereof in constructing transgenic crops degrading diphenyl ether or 2-phenoxybenzoic acid. The angular dioxygenase gene dpeA1A2 consists of an angular dioxygenase large subuni...  
WO/2017/094879A1
The present invention produces a large number of mesenchymal stem cells in a short time in a medium containing no heterologous components by including a step for culturing a cell population containing mesenchymal stem cells in the presen...  
WO/2017/095897A1
A dry stable composition is provided. The composition comprises one or more viable microorganisms, at least 50% by weight of one or more hydrolyzed proteins and less than 10% by weight of one or more sugars selected from the group consis...  
WO/2017/092842A1
The present invention relates to chemically defined culture medium comprising at least glutamine, cysteine and/or cystine, adenine, guanine, aminobenzoic acid, nicotinamide adenine dinucleotide and an iron salt for the rapid detection of...  
WO/2017/095968A1
The present invention provides compositions comprising a probiotic in admixture with an effective amount of an amphipathic substance that enhances viability of the probiotic in the composition when the composition is subjected to heat.  
WO/2017/093345A1
The present invention relates to the field of culturing unicellular red algae (URA). The invention relates in particular to a method for culturing URA, characterised in that the culture medium includes milk permeate as the main contribut...  
WO/2017/095960A1
The present application provides novel regulatory elements including promoter sequences from microorganisms. The application further discloses DNA constructs containing these novel regulatory elements, and recombinant microorganisms comp...  
WO/2017/096260A1
This document describes biochemical pathways for producing 7-aminoheptanoic acid using a β-ketoacyl synthase or a β-keioihiolase to form an N-acetyl-5-amino-3- oxopentanoyl-CoA intermediate. 7-aminoheptanoic acid can be enzymatieally c...  
WO/2017/093114A1
An antibiotic FIIRV 104/18 complex comprising factors F793, F795, F797, F813 and F683, of formula (I), wherein R represents a glycosidic radical as defined in the specification, the isolated individual factors, a method for their product...  
WO/2017/094053A1
A recombinant cell characterized by: having a function of synthesizing acetyl-CoA from methyltetrahydrofolic acid, carbon monoxide and CoA; carrying a gene that expresses an exogenous NAD(P)H consumption pathway, said gene being expresse...  
WO/2017/095269A1
The invention relates to microbiology and medicine and can be used for the prophylaxis and treatment of diseases and conditions associated with the destruction of normal (autochthonous) human or animal microflora (microbiota). In particu...  
WO/2017/093450A1
The present invention relates to a method of producing a recombinant polypeptide a filamentous fungus which is genetically modified to decrease or eliminate the activity of cellulase regulator 2 (CLR2) and to express said recombinant pol...  
WO/2017/092841A1
The present invention relates to chemically defined culture medium comprising at least one osmoprotectant compound and at least one fatty acid for the detection of a broad range of microorganisms.  
WO/2017/094804A1
Docosahexaenoic acid-containing oil containing docosahexaenoic acid in a concentration of 40 wt% or more of the total weight of fatty acids in the oil, and having an endothermic peak temperature determined by differential scanning calori...  
WO/2017/093451A1
The present invention relates to a method of producing a recombinant polypeptide in a filamentous fungus which is genetically modified to decrease or eliminate the activity of cellulase regulator 1 (CLR1) and to express said recombinant ...  
WO/2017/090684A1
The present invention pertains to: a Thermus aquaticus (Taq) polymerase having a strand substitution activity in which a mold DNA binding site of a Taq DNA polymerase is substituted by amino acid residues that increase the total number o...  
WO/2017/090704A1
[Problem] The purpose of the present invention is to provide cranberry-derived lactobacillales that have high immunomodulatory effects and that can suitably be used in food and drink, and to provide food and drink containing the lactobac...  
WO/2017/090055A1
The present invention relates to a modified yeast strain of Saccharomyces cerevisiae having MCC accession number 0069 with osmo-tolerant, thermo-tolerant, ethanol tolerant and self-flocculation properties. Further, the present invention ...  
WO/2017/090724A1
A DNA methylation editing kit including: (1) a fused protein of inactivated CRISPR-associated endonuclease Cas9 (dCas9) having no nuclease activity and a tag peptide array in which a plurality of tag peptides are linked by linkers, or RN...  
WO/2017/090741A1
A particular region, such as a continuous epithelial structure or the like in a cell aggregation, is automatically detected. A region detecting method according to the present invention includes: an input step (S01) for inputting images ...  
WO/2017/088094A1
Provided is a codon-optimized β- mannase signal peptide(MSP), and a nucleotide sequence thereof is shown as SEQ ID NO:1, and a genetically engineered bacteria comprising the signal peptide and the β- mannase, and a method for manufactu...  
WO/2017/088095A1
The present invention provides a signal peptide and application thereof in synthesis of L-arginine from conjac powder and value enhancement of conjac powder. The signal peptide has a nucleotide sequence of SEQ ID NO: 1. The signal peptid...  
WO/2017/085602A1
The present invention relates to media and fermentation methods for producing polysaccharides in bacterial cell culture. In one aspect, the invention relates to a complex culture medium comprising a vegetable hydrolysate, a yeast extract...  
WO/2017/087563A1
Numerous plant microbes, including the vascular-limited Candidatus spp. —causal agents of citrus greening and potato zebra chip diseases— are non-culturable. The present disclosure relates, according to some embodiments, to compositi...  
WO/2017/085235A1
The present invention relates to recombinant Gram-negative bacterial strains and the use thereof for delivery of repeated domains of a heterologous protein or two or more domains of different heterologous proteins into eukaryotic cells.  
WO/2017/083964A1
The present invention discloses uses of mycotoxin-binding antibodies, including antibodies which bind to mycotoxins in feed and feed ingredients resulting in the reduction or elimination of toxic and carcinogenic effects of mycotoxins. T...  
WO/2017/087672A1
Planting corn in one or more consecutive growing seasons in the same fields causes a yield reduction ("corn-on-corn yield penalty"). We developed methods and inoculants comprising Penicillium bilaii, to reduce corn-on-corn yield penalty....  
WO/2017/087505A1
Provided herein are macromolecular structures comprising charged macromolecules. In particular, provided herein are synthetic neutrophil extracellular traps and uses thereof.  
WO/2017/087330A1
The present invention provides in a process of producing ethanol from starch-containing material comprising: (a) saccharifying the starch-containing material; and (b) fermenting using a fermentation organism; wherein saccharification and...  
WO/2017/085520A1
The invention provides compositions comprising bacterial strains for treating and preventing cancer.  
WO/2017/085241A1
The present invention provides a genetically modified microbial cell for production of lysine, comprising a transgene encoding a polypeptide capable of exporting lysine from the cell. The genetically modified microbial cell for productio...  
WO/2017/087731A1
Methods and compositions for the oxidation of short alkanes by engineered microorganisms expressing recombinant enzymes is described, along with methods of use.  
WO/2017/087682A1
Provided here are methods of using a mutated patatin-like phospholipase IIα ("pPLAIIα," renamed here MATRILINEAL) to induce haploid induction in plants, cloning a pPLAIIα to induce haploid induction in plants, and genetically engineer...  
WO/2017/084635A1
The present invention relates to an oral universal influenza vaccine comprising recombinant lactic acid bacteria which express proteins including but not limited to ferritin protein plus highly-conserved stem fragment of hemagglutinin (H...  
WO/2017/086451A1
Provided are: a culture method with which it is possible to obtain active cells, the culture method being characterized in that lactic acid bacteria are bred by a proprietary culture method for culturing while imparting various stresses ...  
WO/2017/081105A1
The invention provides a novel bacterial strain, identified herein as Bacillus subtilis HF1, which shows utility as an agent for controlling plants diseases and also for promoting the growth of animals. The invention provides agents, met...  
WO/2017/083501A1
This disclosure describes, in one aspect, a cell that includes a biocontainment system. Generally, the biocontainment system includes a coding region whose overexpression decreases growth of the cell, a transcription regulatory region th...  
WO/2017/082611A1
The present invention relates to a strain having the ability to inhibit obesity and a pharmaceutical composition containing the same and, more specifically, to a strain having the ability to inhibit obesity by reducing the concentration ...  
WO/2017/080987A3
The present invention relates to a method for improving biomass production and/or growth rate of a microorganism in a fermentation process, said method comprises the steps of: (i) providing one or more microorganism; (ii) providing a fer...  
WO/2017/081274A1
The present invention relates to processes of producing a fermentation product from readily fermentable sugar-material in a fermentation vat comprising a fermentation medium, comprising: feeding the readily fermentable sugar-material int...  
WO/2017/082181A1
Provided is lactic acid bacteria having an enhanced immunostimulatory action, in a state in which an esterified product of a polyhydric alcohol and a fatty acid is not admixed. Also provided is a method for producing lactic acid bacteria...  
WO/2017/082761A1
The invention relates to agricultural microbiology and particularly to Paenibacillus mucilaginosus strain Pm 2906 (VKPM deposit number B-12259), and to a fertiliser based thereon. A fertiliser for crop cultivation is obtained by the step...  
WO/2017/079936A1
Provided is a system expressing a heterologous gene, containing a Listeria bacteria and a recombinant expression vector. Also provided is a method for expressing a target gene containing the system, a biological agent and a method for pr...  
WO/2017/083858A3
The present disclosure relates to a novel method, expression vectors, and host cells for producing nicotinamide riboside by regulating the pathways that lead to the production of nicotinamide riboside.  
WO/2017/083351A1
Non-naturally occurring microorganisms are provided that produce taurine and/or taurine precursors, e.g., hypotaurine, sulfoacetaldehyde, or cysteate, utilizing exogenously added enzyme activities. Methods of producing taurine and/or tau...  
WO/2017/080111A1
Provided is a genetically-engineered strain for producing cadaverine. A lysine decarboxylase promoter 1dcCp is replaced as an environmental/nutritional factor-control promoter, and a signal peptide is expressed at the same time; the lysi...  

Matches 151 - 200 out of 97,368